Literature DB >> 1828792

Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia.

S N Vogel1, B E Henricson, R Neta.   

Abstract

In this study, hypoglycemia induced by injection of lipopolysaccharide (LPS) or the recombinant cytokine interleukin-1 alpha or tumor necrosis factor alpha (administered alone or in combination) was compared. LPS-induced hypoglycemia was reversed significantly by recombinant interleukin-1 receptor antagonist.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1828792      PMCID： PMC258037          DOI： 10.1128/iai.59.7.2494-2498.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  26 in total

1.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Interleukin 1 affects glucose homeostasis.

Authors:  A del Rey; H Besedovsky
Journal:  Am J Physiol       Date:  1987-11

3.  Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody.

Authors:  S N Vogel; E A Havell
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Authors:  W P Arend; H G Welgus; R C Thompson; S P Eisenberg
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

5.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

8.  Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1.

Authors:  S N Vogel; S D Douches; E N Kaufman; R Neta
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

9.  The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.

Authors:  R J North; E A Havell
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307
View more
  18 in total

1.  Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

Authors:  Carl F Raetzsch; Natasha L Brooks; J McKee Alderman; Kelli S Moore; Peter A Hosick; Simon Klebanov; Shizuo Akira; James E Bear; Albert S Baldwin; Nigel Mackman; Terry P Combs
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

2.  A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.

Authors:  M Odeh
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.

Authors:  Senri Oguri; Katsutoshi Motegi; Yoichiro Iwakura; Yasuo Endo
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Falciparum malaria and hypoglycaemia.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

5.  Daily Rhythms of TNFα Expression and Food Intake Regulate Synchrony of Plasmodium Stages with the Host Circadian Cycle.

Authors:  Isabella Cristina Hirako; Patrícia Aparecida Assis; Natália Satchiko Hojo-Souza; George Reed; Helder Nakaya; Douglas Taylor Golenbock; Roney Santos Coimbra; Ricardo Tostes Gazzinelli
Journal:  Cell Host Microbe       Date:  2018-05-24       Impact factor: 21.023

6.  Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates.

Authors:  T S Naotunne; N D Karunaweera; K N Mendis; R Carter
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

7.  Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factor.

Authors:  J L Funk; E J Krul; A H Moser; J K Shigenaga; G J Strewler; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.

Authors:  P Matthys; T Mitera; H Heremans; J Van Damme; A Billiau
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Authors:  J Mancilla; P García; C A Dinarello
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice.

Authors:  M R Hill; R E McCallum
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.